New diabetes clinical trial: Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Published on: 2026-07-22T04:00:00Z
Conditions: Type 2 Diabetes Mellitus (T2DM); Atherosclerosis
Interventions: Drug: Cilostazol; Drug: Aspirin
Sponsors: Seoul National University Bundang Hospital
Recruiting
https://ift.tt/J0DF9UL
Conditions: Type 2 Diabetes Mellitus (T2DM); Atherosclerosis
Interventions: Drug: Cilostazol; Drug: Aspirin
Sponsors: Seoul National University Bundang Hospital
Recruiting
https://ift.tt/J0DF9UL
Comments
Post a Comment